Ambu A/S maintained earnings guidance for the Full-Year 2023/24. For the period,company expects Organic revenue growth of 7%-10%, EBIT margin before special items of 8%-10%.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
133 DKK | -1.95% |
|
-2.38% | +26.90% |
21/06 | Ambu A/S(CPSE:AMBU B) dropped from OMX Copenhagen 20 Index | CI |
15/05 | Nordic Shares Moved Upward Wednesday; BioArctic Series B Topped Leaders | DJ |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.90% | 517.34Cr | |
-4.72% | 18TCr | |
-2.83% | 10TCr | |
-5.01% | 6.69TCr | |
+15.53% | 4.67TCr | |
-8.53% | 4.51TCr | |
+5.82% | 4.16TCr | |
+17.67% | 3.05TCr | |
+14.00% | 2.43TCr | |
-8.08% | 2.36TCr |
- Stock Market
- Equities
- AMBU B Stock
- News Ambu A/S
- Ambu A/S Maintains Earnings Guidance for the Full-Year 2023/24